Last update 12 Dec 2024

JYB-1907

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
JYB 1907, JYB-1907, JYB1907
Target
LRRC32 x TGF-β1
Mechanism
LRRC32 inhibitors(Transforming growth factor beta activator LRRC32 inhibitors), TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
Active Organization
Jemincare Therapeutics Corp.Shanghai Jiyu Pharmaceutical Technology Co., Ltd.Jiangsu Jiye Biopharmaceutical Co., Ltd.Startup
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with JYB-1907
CTR20231895 / RecruitingPhase 1
评价注射用JYB1907在晚期恶性实体瘤患者中的安全性、耐受性、药代动力学和初步有效性的多中心、开放、剂量递增和扩展队列Ⅰ期临床研究
[Translation] A multicenter, open-label, dose-escalation and expansion cohort Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of JYB1907 for injection in patients with advanced malignant solid tumors
NCT05821595 / Not yet recruitingPhase 1
A Phase I, Multi-center, Open-label Study With Dose-escalation and Multiple Expansion Cohorts to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of JYB1907 in Subjects With Advanced Solid Tumors
100 Clinical Results associated with JYB-1907
Login to view more data
100 Translational Medicine associated with JYB-1907
Login to view more data
100 Patents (Medical) associated with JYB-1907
Login to view more data
100 Deals associated with JYB-1907
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1-
Jemincare Therapeutics Corp.
31 Jul 2023
Solid tumorPhase 1
US
Shanghai Jiyu Pharmaceutical Technology Co., Ltd.
04 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free